The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(6-nitro-4-oxo-4H-benzo[e][1,3]thiazin-2-yl)-N-p-tolylpiperazine-1-carbothioamide ID: ALA3883383
PubChem CID: 134131268
Max Phase: Preclinical
Molecular Formula: C20H19N5O3S2
Molecular Weight: 441.54
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(NC(=S)N2CCN(c3nc(=O)c4cc([N+](=O)[O-])ccc4s3)CC2)cc1
Standard InChI: InChI=1S/C20H19N5O3S2/c1-13-2-4-14(5-3-13)21-19(29)23-8-10-24(11-9-23)20-22-18(26)16-12-15(25(27)28)6-7-17(16)30-20/h2-7,12H,8-11H2,1H3,(H,21,29)
Standard InChI Key: OZIGHEHIXXYXHF-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
30.7098 -15.5471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7085 -16.3736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4227 -16.7861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1384 -16.3731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4209 -15.1347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1386 -15.5462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8499 -15.1326 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.8497 -14.3059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1319 -13.8944 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4144 -14.3097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5644 -13.8939 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2787 -14.3070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9897 -13.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9926 -13.0728 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2782 -12.6597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5610 -13.0711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6989 -13.9007 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.7072 -12.6622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4201 -13.0759 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7090 -11.8381 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
37.1347 -12.6653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8479 -13.0832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5621 -12.6733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5643 -11.8483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8463 -11.4348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1352 -11.8470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9926 -16.7889 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9919 -17.6131 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.2791 -16.3762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.2783 -11.4367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 1 1 0
5 6 2 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
8 11 1 0
10 17 2 0
14 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
27 28 2 0
27 29 1 0
2 27 1 0
24 30 1 0
M CHG 2 27 1 29 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 441.54Molecular Weight (Monoisotopic): 441.0929AlogP: 3.39#Rotatable Bonds: 3Polar Surface Area: 91.61Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.07CX LogD: 4.07Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.38Np Likeness Score: -2.28
References 1. Chaudhari K, Surana S, Jain P, Patel HM.. (2016) Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB., 124 [PMID:27569197 ] [10.1016/j.ejmech.2016.08.034 ] 2. Dighe SN, Collet TA.. (2020) Recent advances in DNA gyrase-targeted antimicrobial agents., 199 [PMID:32460040 ] [10.1016/j.ejmech.2020.112326 ]